MTPConnect has launched a new program with industry partners supporting early clinical development of medical devices. The Clinical Translation and Commercialisation - Medtech (CTCM) program is a $19.75 million initiative funded by the Federal Government’s Medical Research Future Fund and will offer financial assistance, educational support and infrastructure access to Australian small to medium-sized enterprises (SMEs).
The Medical Device Partnering Program (led by Flinders University) is proud to be announced as a partner on the program. The other partners are the Medical Technology Association of Australia, Cicada Innovations, the BridgeTech Program and Therapeutic Innovation Australia.
MDPP Director Professor Karen Reynolds said: “MDPP has a 13-year track record of supporting medical device ventures across the innovation life cycle, from ideation to product development to commercialisation. We’re delighted to now join MTPConnect and other partners to deliver the new CTCM program, leveraging our capabilities and extensive networks to assist Australian SMEs achieve key clinical milestones and accelerate the adoption and commercialisation of new devices.”
Further information about the CTCM Program - including guidelines, details about eligibility and how to apply - is available on the MTPConnect website